← Back
$VYNE All transactions

VYNE Therapeutics Inc.

A

$ Value

$7K

Shares

8,681

Price

$1

Filed

Jun 3

Insider

Name

Domzalski David

Title

PRESIDENT AND CEO

CIK

0001727794

Roles

Director Officer

Transaction Details

Transaction Date

2025-06-02

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

454,244

Footnotes

These shares were acquired under the Issuer's Employee Share Purchase Plan ("ESPP") for the ESPP purchase period beginning on December 1, 2024 and ending on May 31, 2025 in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the fair market value closing price of the Issuer's common stock on May 30, 2025 (the last trading day of the offering period). The Reporting Person purchased the maximum number of shares permitted by the terms of the ESPP during the calendar year.

Filing Info

Accession No.

0001415889-25-015382

Form Type

4

Issuer CIK

0001566044

Domzalski David's History

Date Ticker Type Value
2026-03-31 VYNE F $9K
2025-12-31 VYNE F $7K
2025-09-30 VYNE F $4K
2025-06-30 VYNE F $21K
2025-06-02 VYNE A $7K

Other Insiders at VYNE (90d)

Insider Bought Sold Last
Stuart Iain
CHIEF SCIENTIFIC OFFICER
2026-03-31
Domzalski David
PRESIDENT AND CEO
2026-03-31
Harsch Mutya
CHIEF LEGAL OFFICER AND GC
2026-03-31
Zeronda Tyler
CHIEF FINANCIAL OFFICER
2026-03-31